We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 8,695 results
  1. Extraction of Modified Adeno-Associated Virus-Like Particles Displaying Peptides on Their Surface

    Virus-like particles (VLPs) of the adeno-associated virus (AAV) can be produced using the baculovirus expression vector system. Insertion of small...
    Esmeralda Cuevas-Juárez, Laura A. Palomares in Baculovirus
    Protocol 2024
  2. A dual role for adeno-associated virus in human health

    Adeno-associated virus (AAV) differs from most other viruses, as it requires the simultaneous presence of a helper virus for an active infection. Up...

    Natalia M Araujo in Virology Journal
    Article Open access 10 October 2023
  3. Adeno-associated virus genome quantification with amplification-free CRISPR-Cas12a

    Efficient manufacturing of recombinant Adeno-Associated Viral (rAAV) vectors to meet rising clinical demand remains a major hurdle. One of the most...

    Zach Hetzler, Stella M. Marinakos, ... Qingshan Wei in Gene Therapy
    Article 25 March 2024
  4. Adeno-associated virus vectors and neurotoxicity—lessons from preclinical and human studies

    Over 15 years after hepatotoxicity was first observed following administration of an adeno-associated virus (AAV) vector during a hemophilia B...

    Daniel Stone, Martine Aubert, Keith R. Jerome in Gene Therapy
    Article 10 May 2023
  5. Adeno-associated virus infection and its impact in human health: an overview

    Discovered as a contaminant of adenovirus stocks in the 1960s, adeno-associated virus (AAV) is a mono-stranded DNA virus that depends on helper...

    Thaís B Sant’Anna, Natalia M Araujo in Virology Journal
    Article Open access 31 October 2022
  6. Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer

    Recombinant adeno-associated viruses (AAVs) have emerged as promising gene delivery vehicles resulting in three US Food and Drug Administration (FDA)...

    Motahareh Arjomandnejad, Ishani Dasgupta, ... Allison M. Keeler in BioDrugs
    Article Open access 02 March 2023
  7. Rational immunosilencing of a promiscuous T-cell epitope in the capsid of an adeno-associated virus

    Owing to the immunogenicity of adeno-associated viruses (AAVs), gene therapies using AAVs face considerable obstacles. Here, by leveraging ex vivo...

    So ** Bing, Morten Seirup, ... Ronit Mazor in Nature Biomedical Engineering
    Article 23 November 2023
  8. Quality Control for Adeno-Associated Viral Vector Production

    Adeno-associated viral vectors (AAV) are frequently used by neuroscientists to deliver tools, such as biosensors and optogenetic and chemogenetic...
    Ina Ersing, Meghan Rego, ... Melina Fan in Vectorology for Optogenetics and Chemogenetics
    Protocol 2023
  9. Preexisting Neutralizing Antibodies against Different Adeno-Associated Virus Serotypes in Humans and Large Animal Models for Gene Therapy

    Gene therapy is a potential cure for several inherited retinal dystrophies, and adeno-associated virus (AAV) has emerged as a vector of choice for...
    Divya Ail, Deniz Dalkara in Retinal Degenerative Diseases XIX
    Conference paper 2023
  10. Adeno-associated Virus-mediated Ezh2 Knockdown Reduced the Increment of Newborn Neurons Induced by Forebrain Ischemia in Gerbil Dentate Gyrus

    It is established that neurogenesis of dentate gyrus is increased after ischemic insult, although the regulatory mechanisms have not yet been...

    Yoshihide Sehara, Yuki Hashimotodani, ... Hiroaki Mizukami in Molecular Neurobiology
    Article Open access 27 April 2024
  11. Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy

    The number of approved or investigational late phase viral vector gene therapies (GTx) has been rapidly growing. The adeno-associated virus vector...

    Boris Gorovits, Mitra Azadeh, ... Bonnie Wu in The AAPS Journal
    Article 26 April 2023
  12. Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis

    Trastuzumab improves overall survival for HER2+ breast cancer, but its short half-life in the cerebrospinal fluid (~2–4 days) and delivery...

    Marcela S. Werner, Shweta Aras, ... James M. Wilson in Cancer Gene Therapy
    Article 13 March 2024
  13. Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays

    Immunogenicity assessment of Adeno-Associated Virus (AAV) vectors is a critical part of gene therapy drug development. Whether the assays are used...

    Elizabeth Butala-Flores, Thien Nguyen, ... Amanda Hays in Pharmaceutical Research
    Article Open access 25 October 2023
  14. The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency

    Adeno-associated virus (AAV) vector is a critical tool for gene delivery through its durable transgene expression and safety profile. Among many...

    Ryota Nakahama, Aika Saito, ... Kazuo Emoto in Molecular Brain
    Article Open access 08 August 2022
  15. Adeno-associated virus mediated expression of monoclonal antibody MR191 protects mice against Marburg virus and provides long-term expression in sheep

    Vectored monoclonal antibody (mAb) expression mediated by adeno-associated virus (AAV) gene delivery leads to sustained therapeutic mAb expression...

    Amira D. Rghei, Laura P. van Lieshout, ... Sarah K. Wootton in Gene Therapy
    Article 01 September 2022
  16. Immune profiling of adeno-associated virus response identifies B cell-specific targets that enable vector re-administration in mice

    Adeno-associated virus (AAV) vector-based gene therapies can be applied to a wide range of diseases. AAV expression can last for months to years, but...

    Maria Chen, Boram Kim, ... Omid Veiseh in Gene Therapy
    Article 14 November 2022
  17. Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma

    Primary liver cancer, which is scientifically referred to as hepatocellular carcinoma (HCC), is a significant concern in the field of global health....

    Meead Hadi, Omer Qutaiba B. Allela, ... Leila Kalantari in Virology Journal
    Article Open access 12 January 2024
  18. Process Design and Comparison for Batch and Continuous Manufacturing of Recombinant Adeno-Associated Virus

    Recombinant adeno-associated virus (rAAV) is one of the most widely used viral vectors that has been used for gene therapy to treat a variety of...

    Ou Yang, Yinying Tao, ... Marianthi Ierapetritou in Journal of Pharmaceutical Innovation
    Article 05 April 2022
  19. Stable inhibition of choroidal neovascularization by adeno-associated virus 2/8-vectored bispecific molecules

    Neovascular age-related macular degeneration (nAMD) causes severe visual impairment. Pigment epithelium-derived factor (PEDF), soluble CD59 (sCD59),...

    Tinghui Bai, Bohao Cui, ... Hua Yan in Gene Therapy
    Article 03 July 2024
  20. Adeno-associated virus serotype 9 antibody titers in patients with SMA pre-screened for treatment with onasemnogene abeparvovec –routine care evidence

    Spinal muscular atrophy (SMA) is characterized by progressive weakness of skeletal and respiratory muscles. This study aimed to evaluate the...

    Sharon Aharoni, Jacob Bistritzer, ... Yoram Nevo in Gene Therapy
    Article 27 April 2022
Did you find what you were looking for? Share feedback.